Beck Bode LLC’s Globus Medical GMED Stock Holding History

Beck Bode LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-66,051	Closed	-$4.83M	–	116
2025 Q1	$4.83M	Buy	+66,051	New	+$5.46M	0.9%	39

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Beck Bode LLC's GMED Position: Q2 2025 in Review

Beck Bode LLC sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 66,051 shares — an estimated $4.83M sold.

Beck Bode LLC first reported a position in GMED in Q1 2025 and held it in 1 quarter. The position peaked at $4.83M in Q1 2025. 481 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

Beck Bode LLC reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
Beck Bode LLC sold 66,051 Globus Medical shares in Q2 2025, an estimated $4.83M.
Beck Bode LLC first reported a position in Globus Medical in Q1 2025 and held it in 1 quarter.
Beck Bode LLC's Globus Medical position peaked at $4.83M in Q1 2025.
481 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Beck Bode LLC's 13F filing for Q2 2025, filed 8 Aug 2025.